Artificial intelligence (AI) is expected to become a key driver of medical device innovation in 2023, according to data analytics firm and consultancy GlobalData, which predicts increased use of AI across the medical sector.
A spokesperson for the firm points out that AI is growing in several fields globally, with the market expected to reach US$93bn (£71.1bn) in 2023, up 12% from 2022.
Alexandra Murdoch, medical analyst at GlobalData, said: “There are so many good uses for AI in the medical device industry.
“We know that it can be used for data management purposes, remote surgery, diagnostic and procedural assisting, clinical trials, and more. Now is the time to invest in these technologies and advance medical devices.”
“With the help of the Covid-19 pandemic, digital health has become incredibly popular over the last few years.
“While we saw a bit of a slowdown after 2020, digital health measures and telehealth have continued to grow, and are only gaining in popularity.
“As a result, AI will also become increasingly important to ensure demands can be met.”
What’s more, AI can improve medical device manufacturing efficiency and reduce risks through use of machine learning (ML), as computers can process large amounts of data and continuously learn.
The technology can also improve operational efficiency at hospitals and other healthcare facilities by automating and prioritising patient safety, with some AI platforms helping hospitals better manage operational costs through tracking wait times and reducing inpatient and emergency department length of stay.
AI has the capacity to make digital health more accessible and easier for patients through tools such as AI chatbots, which can review a patient’s symptoms and then suggest next steps .